{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:27:49Z","timestamp":1793212069160,"version":"4.5.0"},"reference-count":51,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,4]],"date-time":"2021-01-04T00:00:00Z","timestamp":1609718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","gastrojournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Gastroenterology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1053\/j.gastro.2020.12.036","type":"journal-article","created":{"date-parts":[[2020,12,29]],"date-time":"2020-12-29T02:08:32Z","timestamp":1609207712000},"page":"1584-1598","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":236,"title":["Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis"],"prefix":"10.1053","volume":"160","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1277-1796","authenticated-orcid":false,"given":"Anouk M.","family":"Wijnands","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel E.","family":"de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurice W.M.D.","family":"Lutgens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Hoentjen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sjoerd G.","family":"Elias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bas","family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.gastro.2020.12.036_bib1","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1097\/MIB.0b013e31828029c0","article-title":"Declining risk of colorectal cancer in inflammatory bowel disease: an updated meta-analysis of population-based cohort studies","volume":"19","author":"Lutgens","year":"2013","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.036_bib2","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1136\/gut.2009.179804","article-title":"Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups (update from 2002)","volume":"59","author":"Cairns","year":"2010","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.12.036_bib3","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/ecco-jcc\/jjx008","article-title":"Third European Evidence-based Consensus on Diagnosis and Management of Ulcerative Colitis. Part 1: definitions, diagnosis, extra-intestinal manifestations, pregnancy, cancer surveillance, surgery, and ileo-anal pouch disorders","volume":"11","author":"Magro","year":"2017","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.036_bib4","doi-asserted-by":"crossref","first-page":"384","DOI":"10.14309\/ajg.0000000000000152","article-title":"ACG Clinical Guideline: ulcerative colitis in adults","volume":"114","author":"Rubin","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.036_bib5","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1053\/j.gastro.2009.12.037","article-title":"AGA medical position statement on the diagnosis and management of colorectal neoplasia in inflammatory bowel disease","volume":"138","author":"Farraye","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.036_bib6","first-page":"CD000279","article-title":"Strategies for detecting colon cancer in patients with inflammatory bowel disease","volume":"9","author":"Bye","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1053\/j.gastro.2020.12.036_bib7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.cgh.2018.01.023","article-title":"High risk of advanced colorectal neoplasia in patients with primary sclerosing cholangitis associated with inflammatory bowel\u00a0disease","volume":"16","author":"Shah","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib8","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1093\/ecco-jcc\/jjz114","article-title":"Long-term risk of advanced neoplasia after colonic low-grade dysplasia in patients with inflammatory bowel disease: a nationwide cohort study","volume":"13","author":"de Jong","year":"2019","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.036_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1053\/j.gastro.2013.03.044","article-title":"Risk of colorectal high-grade dysplasia and cancer in a prospective observational cohort of patients with inflammatory bowel disease","volume":"145","author":"Beaugerie","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.036_bib10","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1053\/j.gastro.2020.12.036_bib11","doi-asserted-by":"crossref","first-page":"280","DOI":"10.7326\/0003-4819-158-4-201302190-00009","article-title":"Assessing bias in studies of prognostic factors","volume":"158","author":"Hayden","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1053\/j.gastro.2020.12.036_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s41512-019-0050-0","article-title":"Elaborating on the assessment of the risk of bias in prognostic studies in pain rehabilitation using QUIPS-aspects of interrater agreement","volume":"3","author":"Grooten","year":"2019","journal-title":"Diagn Progn Res"},{"key":"10.1053\/j.gastro.2020.12.036_bib13","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12874-015-0024-z","article-title":"The heterogeneity statistic I(2) can be biased in small meta-analyses","volume":"15","author":"von Hippel","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1053\/j.gastro.2020.12.036_bib14","author":"Higgins"},{"key":"10.1053\/j.gastro.2020.12.036_bib15","first-page":"1","article-title":"Conducting meta-analyses in R with the metafor package","volume":"36","author":"Viechtbauer","year":"2010","journal-title":"J\u00a0Stat Soft"},{"key":"10.1053\/j.gastro.2020.12.036_bib16","doi-asserted-by":"crossref","first-page":"d4002","DOI":"10.1136\/bmj.d4002","article-title":"Recommendations for examining and interpreting funnel plot asymmetry in meta-analyses of randomised controlled trials","volume":"343","author":"Sterne","year":"2011","journal-title":"BMJ"},{"key":"10.1053\/j.gastro.2020.12.036_bib17","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1136\/gut.32.8.900","article-title":"Carcinoma and DNA aneuploidy in Crohn\u2019s colitis--a histological and flow cytometric study","volume":"32","author":"Lofberg","year":"1991","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.12.036_bib18","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1016\/j.cgh.2019.08.032","article-title":"Association between indefinite dysplasia and advanced neoplasia in patients with inflammatory bowel diseases undergoing surveillance","volume":"18","author":"Mahmoud","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib19","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1136\/gut.2003.038505","article-title":"Cancer surveillance in longstanding ulcerative colitis: endoscopic appearances help predict cancer risk","volume":"53","author":"Rutter","year":"2004","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.12.036_bib20","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1093\/ecco-jcc\/jjv108","article-title":"Epithelial dysplasia and cancer in IBD strictures","volume":"9","author":"Sonnenberg","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.036_bib21","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1111\/j.1440-1746.2008.05532.x","article-title":"Risks and clinical features of colorectal cancer complicating Crohn\u2019s disease in Japanese patients","volume":"23","author":"Yano","year":"2008","journal-title":"J\u00a0Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib22","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1093\/ecco-jcc\/jjw048","article-title":"Inflammatory bowel disease phenotype as risk factor for cancer in a prospective multicentre nested case-control IG-IBD study","volume":"10","author":"Biancone","year":"2016","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.036_bib23","doi-asserted-by":"crossref","first-page":"188","DOI":"10.3109\/00365521.2014.989538","article-title":"The risk of colorectal cancer in inflammatory bowel disease: a hospital-based cohort study from Korea","volume":"50","author":"Lee","year":"2015","journal-title":"Scand J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.036_bib24","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/j.cgh.2017.11.041","article-title":"High risk of anal and rectal cancer in patients with anal and\/or perianal Crohn\u2019s disease","volume":"16","author":"Beaugerie","year":"2018","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib25","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s13402-010-0006-4","article-title":"Biomarker-based prediction of inflammatory bowel disease-related colorectal cancer: a case-control study","volume":"34","author":"Gerrits","year":"2011","journal-title":"Cell Oncol (Dordr)"},{"key":"10.1053\/j.gastro.2020.12.036_bib26","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1572-0241.1999.877_f.x","article-title":"Evaluation of the usefulness of testing for p53 mutations in colorectal cancer surveillance for ulcerative colitis","volume":"94","author":"Lashner","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.036_bib27","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1097\/00054725-200606000-00008","article-title":"Risk factors for colorectal cancer in Crohn\u2019s colitis: a case-control study","volume":"12","author":"Siegel","year":"2006","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.036_bib28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1111\/apt.13897","article-title":"The effects of aminosalicylates or thiopurines on the risk of colorectal cancer in inflammatory bowel disease","volume":"45","author":"Carrat","year":"2017","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1053\/j.gastro.2020.12.036_bib29","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1053\/j.gastro.2006.03.028","article-title":"Predictive and protective factors associated with colorectal cancer in ulcerative colitis: a case-control study","volume":"130","author":"Velayos","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.036_bib30","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/ecco-jcc\/jjv145","article-title":"Thiopurine therapy reduces the incidence of colorectal neoplasia in patients with ulcerative colitis. Data from the ENEIDA Registry","volume":"9","author":"Gordillo","year":"2015","journal-title":"J\u00a0Crohns Colitis"},{"key":"10.1053\/j.gastro.2020.12.036_bib31","doi-asserted-by":"crossref","first-page":"2405","DOI":"10.1038\/ajg.2010.248","article-title":"Risk factors for neoplasia in inflammatory bowel disease patients with pancolitis","volume":"105","author":"Bergeron","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.036_bib32","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.cgh.2016.02.017","article-title":"Statin use is associated with reduced risk of colorectal cancer in patients with inflammatory bowel diseases","volume":"14","author":"Ananthakrishnan","year":"2016","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.cgh.2014.06.032","article-title":"A\u00a0rule for determining risk of colorectal cancer in patients with inflammatory bowel disease","volume":"13","author":"Lutgens","year":"2015","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib34","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s10620-009-0942-x","article-title":"Mesalamine protects against colorectal cancer in inflammatory bowel disease","volume":"55","author":"Tang","year":"2010","journal-title":"Dig Dis Sci"},{"key":"10.1053\/j.gastro.2020.12.036_bib35","doi-asserted-by":"crossref","first-page":"54","DOI":"10.5009\/gnl18178","article-title":"Statin exposure is not associated with reduced prevalence of colorectal neoplasia in patients with inflammatory bowel disease","volume":"13","author":"Shah","year":"2019","journal-title":"Gut Liver"},{"key":"10.1053\/j.gastro.2020.12.036_bib36","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/modpathol.3880534","article-title":"Interobserver variability in the diagnosis of ulcerative colitis-associated dysplasia by telepathology","volume":"15","author":"Odze","year":"2002","journal-title":"Mod Pathol"},{"key":"10.1053\/j.gastro.2020.12.036_bib37","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1002\/ibd.21467","article-title":"Misclassification of dysplasia in patients with inflammatory bowel disease: consequences for progression rates to advanced neoplasia","volume":"17","author":"van Schaik","year":"2011","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.036_bib38","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00384-016-2684-5","article-title":"Combining aneuploidy and dysplasia for colitis\u2019 cancer risk assessment outperforms current surveillance efficiency: a meta-analysis","volume":"32","author":"Meyer","year":"2017","journal-title":"Int J Colorectal Dis"},{"key":"10.1053\/j.gastro.2020.12.036_bib39","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1053\/j.gastro.2011.12.004","article-title":"Field cancerization in the intestinal epithelium of patients with\u00a0Crohn\u2019s ileocolitis","volume":"142","author":"Galandiuk","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.036_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1097\/01.mog.0000231812.95525.a7","article-title":"Cancer surveillance in inflammatory bowel disease: new molecular approaches","volume":"22","author":"Risques","year":"2006","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1053\/j.gastro.2020.12.036_bib41","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1136\/gutjnl-2017-314190","article-title":"Cumulative burden of inflammation predicts colorectal neoplasia risk in ulcerative colitis: a large single-centre study","volume":"68","author":"Choi","year":"2019","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.12.036_bib42","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1093\/ibd\/izaa047","article-title":"Cumulative histologic inflammation predicts colorectal neoplasia in ulcerative colitis: a validation study","volume":"27","author":"Yvellez","year":"2021","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.036_bib43","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1016\/j.cgh.2013.06.023","article-title":"Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study","volume":"11","author":"Rubin","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib44","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1053\/j.gastro.2018.11.067","article-title":"No association between pseudopolyps and colorectal neoplasia in patients with inflammatory bowel diseases","volume":"156","author":"Mahmoud","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1053\/j.gastro.2020.12.036_bib45","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/ibd\/izz261","article-title":"No increased risk of colorectal neoplasia in patients with inflammatory bowel disease and postinflammatory polyps","volume":"26","author":"de Jong","year":"2020","journal-title":"Inflamm Bowel Dis"},{"key":"10.1053\/j.gastro.2020.12.036_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/MEG.0000000000000576","article-title":"Increased risk of colorectal neoplasia in patients with primary sclerosing cholangitis and inflammatory bowel disease: a meta-analysis of 16 observational studies","volume":"28","author":"Zheng","year":"2016","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1053\/j.gastro.2020.12.036_bib47","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1136\/gutjnl-2015-311004","article-title":"Primary sclerosing cholangitis is characterised by intestinal dysbiosis independent from IBD","volume":"65","author":"Sabino","year":"2016","journal-title":"Gut"},{"key":"10.1053\/j.gastro.2020.12.036_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/ng.3745","article-title":"Genome-wide association study of primary sclerosing cholangitis identifies new risk loci and quantifies the genetic relationship with inflammatory bowel disease","volume":"49","author":"Ji","year":"2017","journal-title":"Nat Genet"},{"key":"10.1053\/j.gastro.2020.12.036_bib49","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/gim.2014.188","article-title":"Family history and the natural history of colorectal cancer: systematic review","volume":"17","author":"Henrikson","year":"2015","journal-title":"Genet Med"},{"key":"10.1053\/j.gastro.2020.12.036_bib50","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1186\/s12885-018-4786-7","article-title":"A\u00a0review of sex-related differences in colorectal cancer incidence, screening uptake, routes to diagnosis, cancer stage and survival in the UK","volume":"18","author":"White","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1053\/j.gastro.2020.12.036_bib51","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1016\/S0140-6736(19)32319-0","article-title":"Colorectal cancer","volume":"394","author":"Dekker","year":"2019","journal-title":"Lancet"}],"container-title":["Gastroenterology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520355876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0016508520355876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T15:31:58Z","timestamp":1758036718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0016508520355876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":51,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S0016508520355876"],"URL":"https:\/\/doi.org\/10.1053\/j.gastro.2020.12.036","relation":{},"ISSN":["0016-5085"],"issn-type":[{"value":"0016-5085","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prognostic Factors for Advanced Colorectal Neoplasia in Inflammatory Bowel Disease: Systematic Review and Meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Gastroenterology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1053\/j.gastro.2020.12.036","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 by the AGA Institute. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}